Director, 10% Owner · Evommune, Inc. · Common Stock
Side
A
Value
$10.00M
Shares
358.7K
Price
$27.88
Executed
Feb 17, 2026
Disclosed
Feb 18, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Feb 17 executedFeb 18, 2026 disclosed
EVMN · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+14 / 25
$10.0M reported value · 7.3% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Verduyn-van Weegen Felice Isabel filed this Form 4 reporting a grant or award of EVMN on Feb 17, 2026. It became public on Feb 18, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, 10% Owner
Verduyn-van Weegen Felice Isabelcik:0002094941
Issuer
Evommune, Inc.cik:0002044725
Revision history · 0
No field has changed since this record was first ingested.
